pirenzepine has been researched along with Fecal Incontinence in 1 studies
Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
Fecal Incontinence: Failure of voluntary control of the anal sphincters, with involuntary passage of feces and flatus.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mendhekar, DN | 1 |
| Srivastav, PK | 1 |
| Sarin, SK | 1 |
| Jiloha, RC | 1 |
1 other study available for pirenzepine and Fecal Incontinence
| Article | Year |
|---|---|
A case report of olanzapine-induced fecal incontinence.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Fecal Incontinence; Humans; Male; | 2003 |